Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-066923

Chairman and CEO bought 26,300 shares at an average $1.34 ($35,312)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-11-23 Purchase +7,000 $1.35 $9,450 10,953,147 D
Niihara Yutaka Chairman and CEO 2021-11-24 Purchase +19,300 $1.34 $25,862 10,972,447 D
Open-market purchases · 26,300 sh · avg $1.34 · $35,312
Loading xslF345X03/doc4.xml…